IMDX
Insight Molecular Diagnostics Inc.
+0.20 (+5.59%)3.78USD103K成交股數124M市值–本益比(近四季)74.1股價營收比-53.9%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 239K-54% | 32K-99% | 1.1M+890% | 260K+150% | 518K+194% | 2.1M+581% | 115K-73% | 104K-78% | 176K | 314K | 429K | 463K |
| 營業成本 | 82K | 17K | 636K | 121K | 180K | 813K | 43K | 32K | 109K | 409K | 159K | 169K |
| 毛利 | 157K-54% | 15K-99% | 496K+892% | 139K+178% | 338K+651% | 1.3M-1232% | 50K-80% | 50K-82% | 45K | −117K | 248K | 272K |
| 毛利率 | 65.7% | 46.9% | 43.5% | 53.5% | 65.3% | 62.0% | 43.5% | 48.1% | 25.6% | -37.3% | 57.8% | 58.7% |
| 研發費用 | 4.5M | 5.0M | 5.8M | 3.9M | 3.3M | 2.9M | 2.8M | 2.5M | 2.3M | 2.5M | 2.2M | 2.4M |
| 銷售管理費用 | 2.9M | 3.0M | 2.3M | 2.5M | 2.6M | 3.1M | 2.6M | 2.4M | 2.7M | 1.8M | 2.5M | 3.5M |
| 營業利益 | −11.4M+16% | −4.4M-35% | −23.4M+73% | −11.0M+139% | −9.8M+6% | −6.8M-58% | −13.5M+108% | −4.6M-44% | −9.3M | −16.2M | −6.5M | −8.3M |
| 營業利益率 | -4,770.7% | -13,790.6% | -2,057.5% | -4,249.2% | -1,900.0% | -318.0% | -11,752.2% | -4,453.8% | -5,265.3% | -5,152.5% | -1,518.2% | -1,791.4% |
| 稅後淨利 | −11.3M+16% | −4.3M-36% | 27.2M-302% | −10.9M+140% | −9.7M+7% | −6.7M-157% | −13.5M+108% | −4.5M-46% | −9.1M | 11.8M | −6.5M | −8.3M |
| 淨利率 | -4,711.3% | -13,406.3% | 2,389.5% | -4,174.6% | -1,880.7% | -312.0% | -11,733.0% | -4,355.8% | -5,186.9% | 3,745.6% | -1,512.6% | -1,799.8% |
| 稀釋 EPS | -0.31+3% | -0.12-54% | -0.75-23% | -0.34-6% | -0.30-73% | -0.26-89% | -0.98+21% | -0.36-66% | -1.13 | -2.27 | -0.81 | -1.07 |
| 稀釋股數 | 36.8M | 34.5M | 30.5M | 32.0M | 32.0M | 25.7M | 13.7M | 12.9M | 8.3M | 7.7M | 8.3M | 8.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 17.8M | 28.2M | 11.6M | 18.7M | 24.3M | 31.0M | 3.4M | 9.3M | 5.6M | 9.4M | 13.8M | 17.4M |
| 應收帳款 | 192K | 157K | 1.1M | 258K | 512K | 3.5M | 209K | 85K | 161K | 484K | 593K | 593K |
| 存貨 | 207K | 382K | 446K | 471K | 693K | 459K | 232K | – | – | – | – | – |
| 總資產 | 29.4M | 40.4M | 25.8M | 43.9M | 50.5M | 60.4M | 70.2M | 74.7M | 71.0M | 74.9M | 81.6M | 87.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 50.7M | 51.1M | 57.2M | 53.1M | 49.4M | 50.1M | 60.5M | 52.0M | 54.1M | 49.3M | 39.1M | 39.2M |
| 股東權益 | −21.3M | −10.7M | −31.5M | −9.2M | 1.1M | 10.2M | 9.7M | 22.7M | 11.6M | 20.5M | 36.1M | 43.6M |
| 負債比 | 172.3% | 126.4% | 222.2% | 120.9% | 97.8% | 83.1% | 86.2% | 69.6% | 76.2% | 65.8% | 47.9% | 44.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −7.6M+31% | – | – | – | −5.8M | – | – | −3.8M | – | – | – |
| 資本支出 | – | 613K | – | – | – | 307K | – | – | 24K | – | – | – |
| 自由現金流 | – | −8.3M+34% | – | – | – | −6.1M | – | – | −3.9M | – | – | – |
| 折舊攤銷 | 665K | 631K | 563K | 584K | 559K | 491K | 340K | 326K | 335K | 391K | 404K | 435K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -25,787.5% | – | – | – | -287.5% | – | – | -2,189.8% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 4.1M
| 美國 | 4.0M | 99.4% | +140.9% |
|---|---|---|---|
| 歐洲 | 24K | 0.6% | +33.3% |
產品／服務2025 年度 · 4.1M
| Laboratory Services | 4.0M | 99.4% | +116.8% |
|---|---|---|---|
| Kitted Products | 24K | 0.6% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.1M | +115.6% | −50K | -1.2% | -1.65 | −25.4M |
| FY2024 | 1.9M | +25.1% | −61K | -3.2% | -4.66 | −21.2M |
| FY2023 | 1.5M | +56.9% | −28K | -1.8% | -3.75 | −23.6M |
| FY2022 | 958K | -56.4% | −72.9M | -7,609.8% | -13.25 | −49.9M |
| FY2021 | 2.2M | +80.8% | −64.1M | -2,916.2% | -0.72 | −38.2M |
| FY2020 | 1.2M | +306.7% | −29.9M | -2,461.5% | -0.46 | −27.2M |
| FY2019 | 299K | -238.4% | −22.4M | -7,500.3% | -0.44 | −20.6M |
| FY2018 | −216K | – | −15.8M | 7,293.5% | -0.42 | −11.7M |